Valuation: Accuray Incorporated

Market Cap 33.43M 28.64M 26.79M 24.53M 46.03M 3.2B 46.64M 317M 123M 1.61B 126M 123M 5.31B P/E 2026
-0.64x
P/E 2027 * -0.94x
Enterprise Value 33.43M 28.64M 26.79M 24.53M 46.03M 3.2B 46.64M 317M 123M 1.61B 126M 123M 5.31B EV / Sales 2026
0.08x
EV / Sales 2027 * 0.08x
Free-Float
95.66%
Yield 2026 *
-
Yield 2027 * -
1 day-3.90%
1 week+1.01%
Current month+4.81%
1 month+17.97%
3 months-8.44%
6 months-49.99%
Current year-65.92%
1 week 0.28
Extreme 0.2788
0.33
1 month 0.22
Extreme 0.22
0.34
Current year 0.22
Extreme 0.22
0.93
1 year 0.22
Extreme 0.22
2.1
3 years 0.22
Extreme 0.22
3.1
5 years 0.22
Extreme 0.22
5.93
10 years 0.22
Extreme 0.22
6.39
Manager TitleAgeSince
Chief Executive Officer 67 20/10/2025
Director of Finance/CFO 46 09/05/2022
Chief Tech/Sci/R&D Officer - 01/09/2023
Director TitleAgeSince
Chairman 68 01/01/2021
Director/Board Member 65 06/09/2019
Director/Board Member 62 17/08/2021
Date Insider Type Main position Quantity % Market Cap.
28/02/26 Fiscal year

Chief Operating Officer

196,415 0.1733%
20/02/26 Buy

Director

54,875 0.0484%
18/02/26 Buy

Director

195,125 0.1722%
Change 5-day change 1-year change 3-year change Capi.($)
-3.90%+1.01%-82.33%-90.14% 33.43M
+0.27%+6.97%+25.86%+15.41% 233B
+1.36%+8.10%+3.33%-14.13% 154B
+1.16%-3.98%-20.44%+30.45% 134B
+2.03%-2.82%-52.56%+0.04% 73B
+0.44%+3.54%-15.06%-11.68% 52.24B
-0.04%-1.98%+9.73%+18.30% 51.75B
+1.73%+7.05%+30.72%+33.47% 44.91B
+1.49%-0.36%+35.91%+51.53% 40.35B
+1.03%+1.53%-0.53%+8.45% 33.8B
Average +0.35%+1.66%-6.54%+4.17% 81.64B
Weighted average by Cap. +0.75%+3.06%+3.04%+11.87%

Financials

2026 2027 *
Net sales 406M 348M 326M 298M 559M 38.87B 567M 3.85B 1.5B 19.53B 1.53B 1.49B 64.59B 413M 354M 331M 303M 569M 39.52B 576M 3.91B 1.53B 19.85B 1.55B 1.52B 65.66B
Net income -42.6M -36.49M -34.14M -31.25M -58.66M -4.08B -59.43M -403M -157M -2.05B -160M -156M -6.77B -37.9M -32.47M -30.38M -27.81M -52.18M -3.63B -52.87M -359M -140M -1.82B -142M -139M -6.03B
Net Debt - -
Logo Accuray Incorporated
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Employees
990
Date Price Change Volume
21/08/26 $0.2810 -3.90% 466,706
20/08/26 $0.2924 -0.81% 589,621
19/08/26 $0.2948 -6.41% 1,400,348
18/08/26 $0.3150 -3.55% 591,956
17/08/26 $0.3266 +17.40% 1,150,051
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.2810USD
Average target price
0.3500USD
Spread / Average Target
+24.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ARAY Stock